In insulin-naive patients with type 2 diabetes on metformin (± sulfonylureas), once-weekly semaglutide significantly reduced HbA1c and promoted weight loss more effectively than daily insulin glargine, with a lower incidence of hypoglycaemia, though gastrointestinal side effects were more common.
Welcome to Hormone Insight. Our mission is to support clinical decision-making with accessible, evidence-based insights from recent studies and trials.
CATEGORIES
© 2024-2026 Hormone Insight. All rights reserved.